LEIDEN JEFFREY M
SEC Form 4 insider trading activity
LEIDEN JEFFREY M has filed 6 SEC Form 4 filings (30 transaction rows) across 2 companies, including ODTX, VRTX, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: May 12, 2026.
On the most recent filing, LEIDEN JEFFREY M is listed as Director at Odyssey Therapeutics, Inc. Inside the rolling window, LEIDEN JEFFREY M reported 1 open-market purchase totaling $100K in ODTX and 3 open-market sales totaling $60.9M in VRTX. The largest disclosed transaction in the window is a sale of 63,781 VRTX shares on Dec 3, 2025, worth $28.7M.
Companies traded
Other insiders at ODTX
Insider Buying
$100K
reported purchases (SEC code P)
Insider Selling
$60.9M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has LEIDEN JEFFREY M made?
LEIDEN JEFFREY M has filed 6 SEC Form 4 filings (30 transaction rows) across 2 companies, including ODTX, VRTX since 2025.
Which companies does LEIDEN JEFFREY M trade?
LEIDEN JEFFREY M has filed SEC Form 4 disclosures for 2 companies, including ODTX, VRTX.
When was LEIDEN JEFFREY M's most recent SEC Form 4 filing?
LEIDEN JEFFREY M's most recent SEC Form 4 filing on Tracefour is dated May 12, 2026.
What is LEIDEN JEFFREY M's total buy and sell value in the current window?
Inside the rolling retention window, LEIDEN JEFFREY M bought $100K and sold $60.9M based on SEC Form 4 filings.
What was LEIDEN JEFFREY M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 63,781 VRTX shares on 2025-12-03, worth $28.7M, per SEC Form 4 filings.